Lv11
12 积分 2026-09-07 加入
Bispecific Aptamer-Based Recognition-then-Conjugation Strategy for PD1/PDL1 Axis Blockade and Enhanced Immunotherapy
1小时前
待确认
Bivalent OX40 Aptamer and CpG as Dual Agonists for Cancer Immunotherapy
1小时前
待确认
Aptamer-conjugated nano-liposome for immunogenic chemotherapy with reversal of immunosuppression
1小时前
已完结
Aptamer‐Assisted Blockade of the Immune Suppressor Sialic Acid‐Binding Immunoglobulin‐Like Lectin‐15 for Cancer Immunotherapy
1小时前
已完结
皖公网安备34019202002308
